Loading
A phase 1 trial of MTX-531 run by MEKanistic Therapeutics, Inc., not yet recruiting.
MTX-531-001 Phase 1 Study in Advanced Solid Tumors is a phase 1 interventional study registered as NCT07874880 by MEKanistic Therapeutics, Inc., with 71 participants planned, started 2026-10-20. Conditions recorded: Solid Tumors (Phase 1), HNSCC, Endometrial Cancer, Her2-negative Metastatic Breast Cancer, Pan-RAS and BRAF Wild-type Advanced, Metastatic Colorectal Cancer (CRC) and Head and Neck Squamous Cell Carcinoma. Interventions recorded: MTX-531.
Shares MEKanistic Therapeutics and the tag pipeline.
Shares Endometrial cancer, Breast cancer (all types), Metastatic cancer (cancer that has spread), Colorectal cancer and the tag pipeline.
Shares Endometrial cancer, Metastatic cancer (cancer that has spread), Colorectal cancer and the tag pipeline.
Shares Endometrial cancer, Breast cancer (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Endometrial cancer, Metastatic cancer (cancer that has spread), Colorectal cancer and the tag pipeline.
Shares Endometrial cancer, Colorectal cancer and the tag pipeline.
Shares Endometrial cancer, Head and neck squamous cell carcinoma and the tag pipeline.
Shares Endometrial cancer, Head and neck squamous cell carcinoma, Breast cancer (all types), Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/